However, it is worth noting that in previous studies, researchers greatly enhanced the specificity of Tanshinone nanoparticles for prostate cancer tissue by combining them with prostate-specific membrane antigen [60], which provides a way for the development of Tanshinone anti-prostate cancer-related nanoparticles in the future. This evidence concerns the gene FOLH1 and prostate cancer.